Sunday, October 11, 2026
Superceuticals, an integral part of the AIC IIT Delhi ecosystem and recognized by DPIIT, is proud to contribute to the "Make in India" initiative, emphasizing its commitment to indigenous innovation and progress.
Superceuticals, known for its unwavering commitment to transforming healthcare in India, unveiled the revolutionary SC-AN 2.4 product, a state-of-the-art diagnostic and telemedicine marvel. The event that took place at the illustrious IIT Delhi Sonipat campus on Friday, 22nd September attracted a diverse audience of healthcare professionals, researchers, and industry experts.
SC-AN 2.4 is a testament to innovation and is underpinned by a secure software ecosystem that safeguards patient health data. It addresses critical challenges in the healthcare sector by providing instant reports for over 85 medical parameters and offering seamless patient data management.
"We are thrilled to unveil the SC-AN 2.4 product at IIT Delhi Sonipat. This event represents a significant milestone in our mission to improve healthcare accessibility across India. We were delighted to have industry leaders like Shri Sourav Mukherjee, Shri Nalin Kohli, Professor Rajendra Swaroop, and Mr. Avinash Shup join us as we showcased the future of healthcare," said Atman Jadon, Director, Superceuticals.
The attendance of prominent industry provided an opportunity for networking, collaboration, and in-depth discussions on the transformative potential of innovative healthcare solutions.
About Superceuticals
Superceuticals emerged as a beacon of hope in India's healthcare landscape, driven by a vision to transform the way healthcare is delivered in the country. Recognizing the challenges faced by patients, especially in rural and remote areas, the organization embarked on a mission to revolutionize pathology and provide accessible healthcare solutions. The result of this unwavering commitment is SC-AN 2.4, India's first and most advanced diagnostic solution.
.jpeg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)